HANARO MSCI VIROLOGYHANARO MSCI VIROLOGYHANARO MSCI VIROLOGY

HANARO MSCI VIROLOGY

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.53 B‬KRW
Fund flows (1Y)
‪−2.79 B‬KRW
Dividend yield (indicated)
1.43%
Discount/Premium to NAV
0.2%
Shares outstanding
‪150.00 K‬
Expense ratio
0.50%

About HANARO MSCI VIROLOGY


Brand
Amundi
Home page
Inception date
Jun 8, 2022
Index tracked
MSCI World IMI Virology Select Index - KRW - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
NH-Amundi Asset Management Co., Ltd.
ISIN
KR7432850006

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
Developed Markets
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of May 19, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stocks74.25%
Health Technology74.25%
Bonds, Cash & Other25.75%
Cash25.75%
Stock breakdown by region
68%31%
North America68.91%
Europe31.09%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


432850 last dividends amounted to 45.00 KRW. Before that, the issuer paid 50.00 KRW in dividends, which shows a 11.11% decrease.
432850 assets under management is ‪1.53 B‬ KRW. It's risen 1.63% over the last month.
432850 fund flows account for ‪−2.79 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, 432850 pays dividends to its holders with the dividend yield of 1.43%. The last dividend (May 3, 2024) amounted to 45.00 KRW.
432850 shares are issued by HANWHA LIFE INSURANCE Co., Ltd. under the brand Amundi. The ETF was launched on Jun 8, 2022, and its management style is Passive.
432850 expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
432850 follows the MSCI World IMI Virology Select Index - KRW - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
432850 invests in stocks.
432850 price has fallen by −2.42% over the last month, and its yearly performance shows a −16.69% decrease. See more dynamics on 432850 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.33% over the last month, showed a −13.20% decrease in three-month performance and has decreased by −13.48% in a year.
432850 trades at a premium (0.23%) meaning the ETF is trading at a higher price than the calculated NAV.